Focusing on cell culture, providing comprehensive solutions for cell culture

In 2018, Nanjing Qianhe was established as a national first level agent for FUJIFILM Irvine SentificART (assisted reproductive) business.

In 2022, Shanghai Qianhe was established as a national first level agent for FUJIFILM Irvine Scientific BP (biopharmaceutical) and CGT (cell gene therapy) businesses.

In 2023, Qianhe Biotechnology will become the business agent for CBS, Anshengda Azenta, Songyang Biotechnology, and ThermoFisher.

In 2024, Qianhe Biotechnology will become the business agent for Aorui, Lixian, Xinxie, Yushi, Sepp, Shimadzu, Simulate, Merck, Beckman, Yimeisai, Yongnuo, Zhichu, and Silman.

Qianhe Biotechnology is a professional supplier in the field of life sciences that integrates product supply and services. With the mission of "serving life sciences and assisting biomedicine", we strive to promote the development of life sciences in China.